心血管风险评估的最新进展：非侵入性解剖成像的附加价值。
Recent advances in cardiovascular risk assessment: The added value of non-invasive anatomic imaging.
作者信息
Selvam Pooja V, Grandhi Gowtham R, Leucker Thorsten M, Arbab-Zadeh Armin, Gulati Martha, Blumenthal Roger S, Whelton Seamus P
机构信息
Department of Internal Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.
Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
J Cardiovasc Comput Tomogr. 2024 Mar-Apr;18(2):113-119. doi: 10.1016/j.jcct.2024.01.012. Epub 2024 Feb 6.
In 2022, multiple original research studies were conducted highlighting the utility of coronary artery calcium (CAC) imaging in young individuals and provided further evidence for the role of CAC to improve atherosclerotic cardiovascular disease (ASCVD) risk assessment. Mean calcium density was shown to be a more reliable predictor than peak density in risk assessment. Additionally, in light of the ACC/AHA/Multispecialty Chest Pain Guideline's recent elevation of coronary computed tomography angiography (CCTA) to a Class I (level of evidence A) recommendation as an index diagnostic test for acute or stable chest pain, several studies support the utility of CCTA and guided future directions. This review summarizes recent studies that highlight the role of non-invasive imaging in enhancing ASCVD risk assessment across different populations.
2022年，开展了多项原创性研究，突出了冠状动脉钙化（CAC）成像在年轻人中的效用，并为CAC在改善动脉粥样硬化性心血管疾病（ASCVD）风险评估中的作用提供了进一步证据。在风险评估中，平均钙密度被证明是比峰值密度更可靠的预测指标。此外，鉴于美国心脏病学会（ACC）/美国心脏协会（AHA）/多专科胸痛指南最近将冠状动脉计算机断层扫描血管造影（CCTA）提升为I类（证据水平A）推荐，作为急性或稳定胸痛的索引诊断测试，多项研究支持CCTA的效用并为未来方向提供了指导。本综述总结了近期的研究，这些研究突出了非侵入性成像在增强不同人群ASCVD风险评估中的作用。
Zotero 插件